MedTrace Logo

Effect of SLT Location on Treatment Outcomes

NCT03164941 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2017-05-24

No results posted yet for this study

Summary

Selective Laser Trabeculoplasty (SLT) is a glaucoma treatment that has been shown to effectively lower intraocular pressure by increasing aqueous outflow through macrophage recruitment. There is evidence of increased drainage in the nasal quadrants of the eye. This study aims to compare whether there is a difference in the reduction of eye pressure when SLT is performed nasally and temporally.

Conditions

Interventions

PROCEDURE

Selective Laser Trabeculoplasty

Laser treatment for glaucoma.

Sponsors & Collaborators

  • St. Joseph's Healthcare Hamilton

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2019-12-01
Completion
2020-12-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03164941 on ClinicalTrials.gov